Literature DB >> 22646750

Screening for cognitive impairment: comparing the performance of four instruments in primary care.

Tracey Holsinger1, Brenda L Plassman, Karen M Stechuchak, James R Burke, Cynthia J Coffman, John W Williams.   

Abstract

OBJECTIVES: To determine whether brief cognitive screening tests perform as well as a longer screening test in diagnosis of cognitive impairment, no dementia (CIND) or dementia.
DESIGN: A cross-sectional comparison of cognitive screening tests to an independent criterion standard evaluation using Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria. Performance of the cognitive screening tests for identifying dementia, and separately for identifying dementia or CIND, was characterized using sensitivity, specificity, likelihood ratios, and diagnostic odds ratios.
SETTING: Three Department of Veterans Affairs primary care clinics. PARTICIPANTS: Of 826 independently living veterans aged 65 and older without a prior diagnosis of dementia, 639 participated and 630 were assigned a research diagnosis. MEASUREMENTS: Screening tests included the modified Mini-Mental State Examination (3MS; average time to administer, 17 minutes) and three brief instruments: the Memory Impairment Screen (MIS; 4 minutes), the Mini-Cog (3 minutes), and a novel two-item functional memory screen (MF-2; 1.5 minutes).
RESULTS: Participants were aged 74.8 on average and were mostly white or black. They were mostly male (92.9%) and had been prescribed a mean of 7.7 medications for chronic conditions. The prevalence of dementia and CIND was 3.3% and 39.2%, respectively. Sensitivity and specificity for dementia were 86% and 79% for the 3MS, 76% and 73% for the Mini-Cog, 43% and 93% for the MIS, and 38% and 87% for the MF-2, respectively.
CONCLUSION: In individuals without a prior diagnosis of cognitive impairment, the prevalence of dementia was low, but the prevalence of CIND was high. The 3MS and Mini-Cog had reasonable performance characteristics for detecting dementia, but a definitive diagnosis requires additional evaluation.
© 2012, Copyright the Authors Journal compilation © 2012, The American Geriatrics Society.

Entities:  

Mesh:

Year:  2012        PMID: 22646750     DOI: 10.1111/j.1532-5415.2012.03967.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  30 in total

1.  Picture-Based Memory Impairment Screen: Effective Cognitive Screen in Ethnically Diverse Populations.

Authors:  Rubina Malik; Erica F Weiss; Reena Gottesman; Jessica Zwerling; Joe Verghese
Journal:  J Am Geriatr Soc       Date:  2018-05-29       Impact factor: 5.562

2.  Trajectories of Depressive Symptoms in Older Adults and Risk of Dementia.

Authors:  Allison R Kaup; Amy L Byers; Cherie Falvey; Eleanor M Simonsick; Suzanne Satterfield; Hilsa N Ayonayon; Stephen F Smagula; Susan M Rubin; Kristine Yaffe
Journal:  JAMA Psychiatry       Date:  2016-05-01       Impact factor: 21.596

3.  Assessing the Usefulness and Validity of Frailty Markers in Critically Ill Adults.

Authors:  Aluko A Hope; S J Hsieh; Alex Petti; Mariana Hurtado-Sbordoni; Joe Verghese; Michelle Ng Gong
Journal:  Ann Am Thorac Soc       Date:  2017-06

4.  The Rapid Cognitive Screen (RCS): A Point-of-Care Screening for Dementia and Mild Cognitive Impairment.

Authors:  T K Malmstrom; V B Voss; D M Cruz-Oliver; L A Cummings-Vaughn; N Tumosa; G T Grossberg; J E Morley
Journal:  J Nutr Health Aging       Date:  2015-08       Impact factor: 4.075

5.  Self-Administered Cognitive Testing by Older Adults At-Risk for Cognitive Decline.

Authors:  E Tsoy; K L Possin; N Thompson; K Patel; S K Garrigues; I Maravilla; S J Erlhoff; C S Ritchie
Journal:  J Prev Alzheimers Dis       Date:  2020

6.  Barriers and Solutions to Advance Care Planning among Homeless-Experienced Older Adults.

Authors:  Lauren M Kaplan; Rebecca L Sudore; Isabel Arellano Cuervo; Dustin Bainto; Pamela Olsen; Margot Kushel
Journal:  J Palliat Med       Date:  2020-03-17       Impact factor: 2.947

7.  Ability of Bottle Cap Color to Facilitate Accurate Patient-Physician Communication Regarding Medication Identity in Patients with Glaucoma.

Authors:  Pujan Dave; Guadalupe Villarreal; David S Friedman; Malik Y Kahook; Pradeep Y Ramulu
Journal:  Ophthalmology       Date:  2015-08-08       Impact factor: 12.079

8.  Risks and Benefits of Screening for Dementia in Primary Care: The Indiana University Cognitive Health Outcomes Investigation of the Comparative Effectiveness of Dementia Screening (IU CHOICE)Trial.

Authors:  Nicole R Fowler; Anthony J Perkins; Sujuan Gao; Greg A Sachs; Malaz A Boustani
Journal:  J Am Geriatr Soc       Date:  2019-12-02       Impact factor: 5.562

9.  Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.

Authors:  Derjung M Tarn; Maureen Barrientos; Angel Y Wang; Abhijit Ramaprasad; Margaret C Fang; Janice B Schwartz
Journal:  J Am Geriatr Soc       Date:  2019-10-28       Impact factor: 5.562

10.  Predictors of dementia misclassification when using brief cognitive assessments.

Authors:  Janice M Ranson; Elżbieta Kuźma; William Hamilton; Graciela Muniz-Terrera; Kenneth M Langa; David J Llewellyn
Journal:  Neurol Clin Pract       Date:  2019-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.